Kerry Acquires Wellmune® from Biothera Inc.
Tralee, Ireland and Eagan, Minnesota, U.S.A. ─ October 21, 2015 ─ Kerry Group plc, the global taste and nutrition company, has acquired Wellmune® from Biothera Inc., a natural food, beverage and supplement ingredient that is clinically proven to help strengthen the immune system.
“At Kerry, cutting-edge science and technology informs everything we help shape and create. The addition of Wellmune to our portfolio offers Kerry tremendous growth opportunities globally,” said Michael O’Neill, Nutrition President, Kerry. “This natural immunity enhancer strengthens our nutrition and general wellness capabilities and complements our taste solutions for applications in food, beverages, and supplements.”
“The combination of Biothera’s technology and Kerry’s leadership in R&D, nutritional science, and forward looking market insights, will advance the science of immune health and help create new and innovative food, beverages and supplements,” said Richard G. Mueller, Chief Executive Officer of Biothera. “Wellmune is a great fit for Kerry’s portfolio of science-based, nutritional ingredients.”
Wellmune is a 100% natural food, beverage, and supplement ingredient, that strengthens the immune system, making it easier for consumers to be well and stay well. Backed by more than 10 clinical studies, this proprietary yeast beta 1,3/1,6 glucan has regulatory approval in major markets around the world. Products with Wellmune are available in more than 60 countries. Wellmune is patented, Kosher, Halal, non-allergenic, GMO-free, gluten-free and Informed-Sport Certified. For more information, visit http://www.wellmune.com or follow Wellmune on Facebook, Twitter and YouTube.
About Kerry Group
Kerry Group today is a world leader in Taste & Nutrition serving the food, beverage and pharmaceutical industries and a leading consumer foods processing and marketing organisation. The Kerry organisation has grown to become a highly successful public company, having achieved sustained profitable growth with current annualised sales in excess of €5.8 billion. Launched as a public company in 1986, the market capitalisation of the Group has grown to a current level of approximately €12 billion. Kerry Group now employs over 24,000 people throughout its worldwide activities and operations.
Director of Corporate Affairs
+353 66 7182304
Director, Marketing Communications
Biothera Health Inc.
+1 651-312-5848 (direct)